NCT/Study#
NCT04458831 /
IONA OBS16577
A Prospective, Non-Interventional, Multinational, Observational Study With Isatuximab In Patients With Relapsed And/Or Refractory Multiple Myeloma (RRMM)
DISEASE GROUP:
Multiple Myeloma
current phase:
N/A
STUDY STATUS:
Accepting Patients
Location:
Freehold, NJ, Howell, NJ, Little Silver, NJ
For More information:
Call 201-518-3587
